Literature DB >> 15220418

Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation.

Atsushi Kato1, Case Cortese-Grogan, Sue A Moyer, Fumihiro Sugahara, Takemasa Sakaguchi, Toru Kubota, Noriyuki Otsuki, Masayoshi Kohase, Masato Tashiro, Yoshiyuki Nagai.   

Abstract

Sendai virus (SeV) encodes two accessory proteins, V and C, in the alternative reading frames in the P gene that are accessed transcriptionally (V) or translationally (C). The C protein is expressed as a nested set of four C-coterminal proteins, C', C, Y1, and Y2, that use different initiation codons. Using HeLa cell lines constitutively expressing the various C proteins, we previously found that the smallest (the 175-residue Y2) of the four C proteins was fully capable of counteracting the antiviral action of interferons (IFNs) and inhibiting viral RNA synthesis and that the C-terminal half of 106 residues was sufficient for both of these inhibitory functions (A. Kato et al., J. Virol. 75:3802-3810, 2001, and A. Kato et al., J. Virol. 76:7114-7124, 2002). Here, we further generated HeLa cell lines expressing the mutated C (Cm) proteins with charged amino acids substituted for alanine residues at either positions 77 and 80; 114 and 115; 139 and 142; 151, 153, and 154; 156; or 173, 175, and 176. We found that only the mutations at positions 151, 153, and 154 abolished IFN antagonism. All the Cm proteins lost the ability to bind with STAT1 under our assay conditions, regardless of their ability to inhibit IFN signaling. On the other hand, the Cm proteins that altered the tyrosine phosphorylation and dephosphorylation of STAT1 and STAT2 always retained IFN antagonism. Thus, the abnormality of phosphorylation or dephosphorylation appeared to be a cause of the IFN antagonism by SeV C. Regarding viral RNA synthesis inhibition, all mutants but the mutant with replacements at positions 114 and 115 greatly reduced the inhibitory activity, indicating that anti-RNA synthesis by the C protein is governed by amino acids scattered across its C-terminal half. Thus, amino acid sequence requirements differ greatly between IFN antagonism and RNA synthesis inhibition. In addition, we confirmed that another SeV accessory protein, V, does not antagonize IFN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220418      PMCID: PMC434076          DOI: 10.1128/JVI.78.14.7443-7454.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

2.  Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

Authors:  C Huang; K Kiyotani; Y Fujii; N Fukuhara; A Kato; Y Nagai; T Yoshida; T Sakaguchi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha.

Authors:  T Kubota; N Yokosawa; S Yokota ; N Fujii
Journal:  Biochem Biophys Res Commun       Date:  2001-04-27       Impact factor: 3.575

4.  Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role.

Authors:  M K Hasan; A Kato; M Muranaka; R Yamaguchi; Y Sakai; I Hatano; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides.

Authors:  A Portner; K C Gupta; J M Seyer; E H Beachey; D W Kingsbury
Journal:  Virus Res       Date:  1986-11       Impact factor: 3.303

6.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.

Authors:  A Kato; Y Ohnishi; M Kohase; S Saito; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Authors:  J P Parisien; J F Lau; J J Rodriguez; B M Sullivan; A Moscona; G D Parks; R A Lamb; C M Horvath
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

9.  Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing.

Authors:  Noriko Fukuhara; Cheng Huang; Katsuhiro Kiyotani; Tetsuya Yoshida; Takemasa Sakaguchi
Journal:  Virology       Date:  2002-08-01       Impact factor: 3.616

10.  Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.

Authors:  J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  25 in total

Review 1.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

2.  Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.

Authors:  Adriana Forero; Nicholas S Giacobbi; Kevin D McCormick; Ole V Gjoerup; Christopher J Bakkenist; James M Pipas; Saumendra N Sarkar
Journal:  J Immunol       Date:  2014-05-05       Impact factor: 5.422

3.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

Review 4.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

5.  Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells.

Authors:  Rémi Villenave; Olivier Touzelet; Surendran Thavagnanam; Severine Sarlang; Jeremy Parker; Grzegorz Skibinski; Liam G Heaney; James P McKaigue; Peter V Coyle; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

6.  Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.

Authors:  John C Kash; Elke Mühlberger; Victoria Carter; Melanie Grosch; Olivia Perwitasari; Sean C Proll; Matthew J Thomas; Friedemann Weber; Hans-Dieter Klenk; Michael G Katze
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Mumps virus V protein antagonizes interferon without the complete degradation of STAT1.

Authors:  Toru Kubota; Noriko Yokosawa; Shin-Ichi Yokota; Nobuhiro Fujii; Masato Tashiro; Atsushi Kato
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection.

Authors:  Jim B Boonyaratanakornkit; Emmalene J Bartlett; Emerito Amaro-Carambot; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

9.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

Authors:  Jacquelyn R Bedsaul; Luna A Zaritsky; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2016-08-10       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.